Targeted Interventions for Successful Transition and Transfer of Adolescents With Inborn Errors of Metabolism to Adult Metabolic Services

Sponsor
University Children's Hospital, Zurich (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05413278
Collaborator
(none)
20
8
1
40
2.5
0.1

Study Details

Study Description

Brief Summary

Main aims of this project are

  • To assess the baseline status-quo of transition and "fitness for transfer" in terms of information about the adult centre and team, organisational and practical skills (blood sampling and sending, how to make an appointment etc.), disease- and treatment-related knowledge, health-related quality of life (HrQoL), and self-efficacy in adolescnets with inborn errors of metabolism. Biochemical or physical parameters as appropriate for the respective diseases from 12 months before are documented.

  • To provide targeted, structured intervention modules (using available and, if necessary, adapted materials).

  • To measure the effects of these interventions on information about adult services short-term (within a month) and to re-assess all other baseline status-quo parameters long-term (6 and 12 months later). Psychological assessments will be complemented by biochemical or physical parameters as appropriate for the respective diseases and indicative for transition success.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Behavioral
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Fit for Transfer: Targeted Interventions for Successful Transition and Transfer of Adolescents With Inborn Errors of Metabolism to Adult Metabolic Services
Anticipated Study Start Date :
Sep 1, 2022
Anticipated Primary Completion Date :
Sep 1, 2025
Anticipated Study Completion Date :
Dec 31, 2025

Arms and Interventions

Arm Intervention/Treatment
Other: Training

Patient education, empowerment, and information

Behavioral: Behavioral
Patient education, information and empowerment

Outcome Measures

Primary Outcome Measures

  1. Disease and treatment knowledge [Change from baseline to 1 month]

    Questionnaire, specifically constructed during project

Eligibility Criteria

Criteria

Ages Eligible for Study:
14 Years to 25 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria:Patients

  • with an inborn error of metabolism in the care of a specialized metabolic care unit

  • requiring specialized adult metabolic care

  • at least 14 years old

  • with a disease for which at least one biochemical and / or physical parameter disease marker is well established .

Exclusion Criteria:

Patients -

  • with insufficient knowledge of the German

  • with cognitive impairment to a degree that consent, and participation would be impossible

  • in an end-of-life situation

  • with a disease for which no biochemical and / or physical parameter disease marker is well established

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Childrens Hospital Vienna Vienna Austria 1090
2 University Hospital Vienna Vienna Austria 1090
3 University Childrens Hospital Basel Basel Switzerland
4 University Hospital Basel Basel Switzerland
5 University Childrens Hospital Bern Bern Switzerland
6 University Hospial Bern Bern Switzerland
7 University Childrens Hospital Zürich Zürich Switzerland 8032
8 University Hospital Zurich Zürich Switzerland

Sponsors and Collaborators

  • University Children's Hospital, Zurich

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Children's Hospital, Zurich
ClinicalTrials.gov Identifier:
NCT05413278
Other Study ID Numbers:
  • Fit_for_transfer
First Posted:
Jun 10, 2022
Last Update Posted:
Jun 10, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 10, 2022